NJ State Employees Deferred Compensation Plan’s Cardiovascular Systems, Inc. CSII Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8,000	Closed	-$263K	–	506
2021 Q3	$263K	Hold	8,000	–	–	0.04%	426
2021 Q2	$341K	Hold	8,000	–	–	0.05%	382
2021 Q1	$307K	Hold	8,000	–	–	0.04%	398
2020 Q4	$350K	Hold	8,000	–	–	0.05%	345
2020 Q3	$315K	Hold	8,000	–	–	0.06%	317
2020 Q2	$252K	Hold	8,000	–	–	0.05%	360
2020 Q1	$282K	Hold	8,000	–	–	0.06%	299
2019 Q4	$389K	Hold	8,000	–	–	0.07%	335
2019 Q3	$380K	Sell	8,000 -2,000	-20%	-$94K	0.07%	320
2019 Q2	$429K	Hold	10,000	–	–	0.08%	320
2019 Q1	$387K	Hold	10,000	–	–	0.07%	354
2018 Q4	$285K	Buy	10,000 +1,000	+11%	+$31.8K	0.06%	391
2018 Q3	$352K	Hold	9,000	–	–	0.06%	406
2018 Q2	$291K	Sell	9,000 -1,000	-10%	-$27.5K	0.05%	430
2018 Q1	$219K	Hold	10,000	–	–	0.04%	446
2017 Q4	$237K	Hold	10,000	–	–	0.04%	433
2017 Q3	$282K	Sell	10,000 -5,000	-33%	-$152K	0.05%	404
2017 Q2	$483K	Hold	15,000	–	–	0.09%	292
2017 Q1	$424K	Buy	+15,000	New	+$398K	0.08%	287

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's CSII Position: Q4 2021 in Review

NJ State Employees Deferred Compensation Plan sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2021, closing a stake of 8,000 shares — an estimated $263K sold.

NJ State Employees Deferred Compensation Plan first reported a position in CSII in Q1 2017 and held it in 19 quarters. The position peaked at $483K in Q2 2017. 167 funds tracked by Wall St. Rank hold CSII as of Q4 2021.

NJ State Employees Deferred Compensation Plan reported no remaining Cardiovascular Systems, Inc. position as of Q4 2021 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 8,000 Cardiovascular Systems, Inc. shares in Q4 2021, an estimated $263K.
NJ State Employees Deferred Compensation Plan first reported a position in Cardiovascular Systems, Inc. in Q1 2017 and held it in 19 quarters.
NJ State Employees Deferred Compensation Plan's Cardiovascular Systems, Inc. position peaked at $483K in Q2 2017.
167 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2021.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2021, filed 31 Jan 2022.